Yousif Jihad

Dr. Yousif Jihad

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
SMSedeek Mosaid
Sedeek Mosaid
Paul Y F LeePaul Y F Lee
Paul Y F Lee
YJYousif Jihad
Yousif Jihad
Achilles tendon injuries are among the most frequent and debilitating musculoskeletal conditions, often resulting in incomplete healing and functional deficits. Conventional repair techniques primarily restore structural continuity but rarely achieve full biomechanical or histological regeneration. Recent advances in tissue engineering have introduced innovative strategies combining biomimetic scaffolds, cellular therapy, growth factors, and mechanical loading to promote regenerative rather than fibrotic repair. This review summarises the current understanding of Achilles tendon biology and healing mechanisms, with a focus on the integration of stem cell technologies, scaffold design, and mechanobiological conditioning. Various scaffold systems, including natural, synthetic, hybrid, and hydrogel-based constructs, are evaluated for their biocompatibility, mechanical performance, and tenoinductive potential. Preclinical studies demonstrate that mesenchymal stem cell (MSC)-loaded scaffolds exhibit significantly enhanced biomechanical outcomes in tendon defect models, including improved tensile strength, organized collagen I deposition and aligned fibre architecture in repaired constructs. While preclinical results are promising, clinical translation remains limited by regulatory, economic, and methodological challenges. Future research should prioritise standardised protocols, long-term functional outcomes, and interdisciplinary collaboration.

11 July 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
SMSedeek Mosaid
Sedeek Mosaid
YJYousif Jihad
Yousif Jihad
MJMostafa Jihad
Mostafa Jihad
AMAshok Marudanayagam
Ashok Marudanayagam
Paul Y F LeePaul Y F Lee
Paul Y F Lee
Focal articular cartilage defects retain limited intrinsic repair capacity owing to the avascular, alymphatic and aneural nature of hyaline cartilage. Marrow-stimulation procedures often generate mechanically inferior fibrocartilage with declining benefit within 2–5 years in larger or high-demand lesions, while matrix-induced autologous chondrocyte implantation (MACI) achieves durable 10-year benefit but remains constrained by two-stage logistics, in vitro dedifferentiation and cost. This review integrates the cellular, biomaterial, biochemical and immunological dimensions of articular cartilage tissue engineering with quantitative benchmarks and a critical reading of failure modes, scalability and regulatory standing. We benchmark MACI against single-stage chondron- and progenitor-based therapies; examine mesenchymal stromal cells (MSCs) from bone marrow, adipose, synovium and the infrapatellar fat pad with a mechanistic dissection of the Wnt/β-catenin, IHH–PTHrP, RUNX2/MEF2C and HIF-1α inputs driving hypertrophic drift; reframe scaffolds as bioinstructive environments delivering mechanical, biochemical and tribological cues, including stimuli-responsive and 4D-printed systems and low-intensity pulsed ultrasound (LIPUS) as a non-invasive adjunct; develop the immunological dialogue between altered native cartilage, the infrapatellar fat pad–synovium unit and engineered constructs; and appraise CRISPR-based cell engineering and artificial-intelligence applications in biofabrication. We classify the principal approaches into four explicit translational tiers so that the evidentiary standing of each strategy is transparent. Translation will be paced by standardised potency assays, immune-aware construct design and robust long-term in vivo evidence.

17 July 2026 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
SMSedeek Mosaid
Sedeek Mosaid
YJYousif Jihad
Yousif Jihad
MJMostafa Jihad
Mostafa Jihad
AMAshok Marudanayagam
Ashok Marudanayagam
Paul Y F LeePaul Y F Lee
Paul Y F Lee
Background/Objectives: Total ankle arthroplasty (TAA) is increasingly used to treat end-stage ankle arthritis, but comprehensive cross-registry data on revision patterns remain limited. This study describes indications, causes, and patient risk factors for revisions using three national registries. Methods: Aggregate data were extracted from the UK National Joint Registry (NJR; 22nd Annual Report 2025; n = 11,321), the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR; 2025 Ankle Supplementary Report; n = 5379), and the Swedish Ankle Registry (SwedAnkle; Annual Report 2024; n = 1852; survival estimates from a published sub-cohort, n = 1226). Metrics were compared descriptively without inferential pooling. Results: Across registries, 18,552 primary TAAs were identified. Ten-year cumulative per cent revision (CPR) was 9.54% (95% confidence interval [CI], 8.75–10.39) in the NJR, 13.5% (95% CI, 12.1–15.1) in the AOANJRR osteoarthritis sub-cohort, and approximately 26% (author-derived from Kaplan–Meier curves; see Methods) in SwedAnkle (1993 onwards implants). Aseptic loosening was the predominant cause of revision in all three registries; the rank of subsequent causes differed between registries (infection was second in the NJR and AOANJRR; in SwedAnkle, infection ranked below insert wear/breakage at 11.5%). AOANJRR Cox analysis identified younger age (hazard ratios (HRs), 2.00 for <55 vs. ≥75 years; 95% CI, 1.30–3.07; p = 0.001), earlier surgical era (HR, 1.91 for pre-2015 vs. 2015–2024; 95% CI, 1.53–2.38; p < 0.001), and obesity (HR, 1.52 for body mass index (BMI) ≥ 30; 95% CI, 1.06–2.19; p = 0.023) as significant independent predictors in AOANJRR Cox proportional hazards models (osteoarthritis sub-cohort for age, sex, BMI and ASA; all-diagnoses primary cohort for surgical era). Sex and American Society of Anesthesiologists (ASA) scores were not significant. Conclusions: Aseptic loosening was the predominant cause of revision in all three registries. The rank of subsequent causes differed: in the NJR and AOANJRR, infection was the second most frequent cause; in SwedAnkle, infection ranked below insert wear/breakage. Younger age, obesity, and earlier surgical era were independent predictors of revision in AOANJRR Cox proportional hazards models. The post-2015 era was associated with approximately 48% lower revision hazard; this association cannot be interpreted causally, as the independent contributions of implant design, surgical technique, patient selection, and other secular changes cannot be isolated from registry data. These findings may inform preoperative counselling, implant selection, and registry harmonisation efforts.

19 September 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
SMSedeek Mosaid
Sedeek Mosaid
YJYousif Jihad
Yousif Jihad
NPNuala Pepper
Nuala Pepper
MEMohamed A I K Elnemr
Mohamed A I K Elnemr
AMAshok Marudanayagam
Ashok Marudanayagam
Paul Y F LeePaul Y F Lee
Paul Y F Lee
Fragility fracture and osteoporotic bone loss represent an increasing global burden in ageing populations: the Global Burden of Disease Study 2021 estimated 172.79 million new fractures, 453.31 million prevalent cases, and 25.18 million years lived with disability in 2021, yet the resulting defects are still managed with grafts and scaffolds validated in healthy bone. Osteoporotic bone is not merely rarefied normal bone but a distinct regenerative microenvironment, in which we propose that oxidative stress, cellular senescence, and loss of osteogenesis-coupled type-H vasculature act as a mutually reinforcing triad, superimposed on an adipogenically biassed progenitor pool, blunted osteocyte mechanotransduction and immunosenescence. Additive manufacturing and biofabrication permit patient-specific geometry and spatial and temporal programming of mechanical and biological cues. This review appraises four interdependent design axes—mechanical adaptation through functionally graded, trabecular-mimetic architectures; redox regulation; senescence modulation; and osteoimmunomodulation coupled to vascularisation—distinguishing study type, disease specificity and author-proposed hypotheses. The most direct clinical signal is mechanical: in a retrospective cohort of 163 lumbar interbody fusion levels, printed porous titanium was associated with subsidence in 5.5% of levels versus 24.4% for solid titanium. By contrast, almost all redox, senescence and immunomodulatory scaffold evidence remains preclinical: osteoporosis-specific evidence relies heavily on ovariectomised rodents, and much of the rest comes from non-osteoporotic models. Within the searches described, we identified no completed clinical evaluation with reported results of a multifunctional scaffold in an osteoporosis-defined cohort. As the authors’ proposed conceptual framework rather than an established result, we suggest that these axes be engaged sequentially rather than additively, and that timing, dose and spatial distribution may matter more than the number of bioactivities.

16 July 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
SMSedeek Mosaid
Sedeek Mosaid
YJYousif Jihad
Yousif Jihad
MJMostafa Jihad
Mostafa Jihad
AMAshok Marudanayagam
Ashok Marudanayagam
PLPaul Lee
Paul Lee
Massive segmental bone defects present significant challenges in orthopaedic and maxillofacial reconstruction. As defect size increases, the disparity between tissue volume and diffusion-limited biological processes becomes more pronounced. This narrative review analyses distinctions between centimetre-scale defects and conventional fractures and evaluates current tissue-engineering strategies in relation to vascularisation, osteogenesis, mechanical stability, immune response, neural integration, and manufacturability. This review synthesises evidence from scaffold design, cell-based approaches, growth factor delivery, type-H vessel biology, NGF–TrkA signalling, large-animal models, and early clinical translation. Current findings indicate that no single scaffold, cell source, or growth factor can reliably reproduce the coordinated biological and mechanical environment required for durable regeneration of human long bones. The strongest preclinical evidence is derived from ovine tibial models employing medical-grade polycaprolactone/β-tricalcium phosphate composites or mechanobiologically optimised titanium lattices. Human data remain limited to case reports and small early clinical series, including hybrid vascularised flap–scaffold reconstructions. Successful clinical translation will require patient-specific constructs that integrate rapid vascularisation, appropriate load sharing, immune-compatible degradation, infection control, and scalable manufacturing. Until robust comparative clinical evidence emerges, established reconstructive methods will remain the standard of care. Hybrid vascularised scaffold-guided strategies should be regarded as promising translational approaches rather than definitive solutions.

29 January 2026
Verified
Book Chapter
Open access
PDF file
SMSedeek Mosaid
Sedeek Mosaid
AMAshok Marudanayagam
Ashok Marudanayagam
Paul Y F LeePaul Y F Lee
Paul Y F Lee
YJYousif Jihad
Yousif Jihad
RSRizwan Shahid
Rizwan Shahid
Calcaneal fractures represent the most prevalent type of tarsal fractures, comprising up to 75% of all foot fractures. The injuries tend to be related to high-energy trauma. The complex three-dimensional anatomy, multiple classification systems, and condition of the soft tissue envelope make the diagnosis and treatment of these fractures challenging in the affected patient. This chapter provides an updated review of the epidemiology, anatomy, and mechanisms of injury, as well as a detailed discussion of the classification of calcaneal fractures. The various treatment options, including nonoperative treatment, percutaneous treatment, open reduction, and internal fixation via extended lateral, sinus tarsi, and medial approaches, are discussed in detail. The use of subtalar arthroscopy and primary arthrodesis is also reviewed in the context of fracture patterns and patient-specific factors. Postoperative care, with an emphasis on early mobilisation and weight-bearing, is reviewed, with new data supporting an accelerated functional rehabilitation. In conclusion, the successful management of calcaneal fractures depends on an accurate assessment of the patient, meticulous management, and a proper choice of surgical technique, as well as a judicious decision-making process that is tailored to the patient’s specific needs. The future of calcaneal fracture management will require higher-level evidence and the incorporation of emerging new technologies.